112 related articles for article (PubMed ID: 7295098)
1. Potential role of middle molecular compounds in the development of uremic anemia.
Leber HW; Debus E; Grulich U; Schütterle G
Artif Organs; 1981; 4 Suppl():63-7. PubMed ID: 7295098
[TBL] [Abstract][Full Text] [Related]
2. Influence of middle molecules on the anemia of uremic patients.
Leber HW; Spiegelhalter R; Ulm A; Goubeaud G; Rawer P
Artif Organs; 1978 Nov; 2(4):378-81. PubMed ID: 743010
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and delta-ALA-D activity in chronic renal failure patients.
da Silva AC; Rocha JB; Morsch AL; Zanin RF; Kaizer R; Maldonado PA; Arantes LC; Silva LA; Morsch VM; Schetinger MR
Biomed Pharmacother; 2007; 61(2-3):180-5. PubMed ID: 17383846
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Heme synthesis in anemia of the uremic state.
Linkesch W; Stummvoll HK; Wolf A; Müller M
Isr J Med Sci; 1978 Nov; 14(11):1173-6. PubMed ID: 750546
[TBL] [Abstract][Full Text] [Related]
6. In vitro cytotoxic properties of plasma fractions from uremic patients.
Delaporte C; Gros F; Jonsson C; Bergström J
Artif Organs; 1981; 4 Suppl():68-70. PubMed ID: 7295099
[TBL] [Abstract][Full Text] [Related]
7. The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity?
Vanholder R; Van Laecke S; Glorieux G
J Nephrol; 2008; 21(2):146-60. PubMed ID: 18446708
[TBL] [Abstract][Full Text] [Related]
8. Guanidino compounds as uremic (neuro)toxins.
De Deyn PP; Vanholder R; Eloot S; Glorieux G
Semin Dial; 2009; 22(4):340-5. PubMed ID: 19708978
[TBL] [Abstract][Full Text] [Related]
9. The role of erythrocytes phosphatidylserine exposure in anemia in peritoneal dialysis patients.
Bi SH; Cheng LT; Wang T
Ren Fail; 2006; 28(7):573-6. PubMed ID: 17050240
[TBL] [Abstract][Full Text] [Related]
10. Reduced superoxide dismutase activity in erythrocytes of dialysis patients: a possible factor in the etiology of uremic anemia.
Shainkin-Kestenbaum R; Caruso C; Berlyne GM
Nephron; 1990; 55(3):251-3. PubMed ID: 2370923
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the anemia of renal failure participates in overall uremic toxicity.
Kokot F; Wiecek A
Kidney Int Suppl; 1997 Nov; 62():S83-6. PubMed ID: 9350689
[No Abstract] [Full Text] [Related]
13. [Research on some erythrocytic abnormalities in chronic uremic patients in conservative and dialytic therapy].
Lamperi S; Sitia L; Bandiani G; Muttini P
Minerva Nefrol; 1970; 17(6):175-80. PubMed ID: 5516050
[No Abstract] [Full Text] [Related]
14. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
Li G; Chu J; Liu X; Yuan Z
Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
[TBL] [Abstract][Full Text] [Related]
15. [Uremic toxins].
Vanholder R
Nephrologie; 2003; 24(7):373-6. PubMed ID: 14650749
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and clinical evidence for uremic toxicity.
Bouré T; Vanholder R
Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
[TBL] [Abstract][Full Text] [Related]
17. Effect of haemodialysate and its peptide fractions on acetylcholinesterase activity in erythrocytes from healthy subjects and patients with terminal renal failure.
Smoleński O; Tabarowski Z; Miszta H; Dabrowski Z
Int Urol Nephrol; 1993; 25(5):503-8. PubMed ID: 8270380
[TBL] [Abstract][Full Text] [Related]
18. [Middle-molecular uremic toxins (review of the literature)].
Tupikova ZA
Vopr Med Khim; 1983; 29(1):2-10. PubMed ID: 6340339
[No Abstract] [Full Text] [Related]
19. A bench to bedside view of uremic toxins.
Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
[TBL] [Abstract][Full Text] [Related]
20. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.
Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T
Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
